No Detail Found!

Comparative Analysis of Low Molecular Weight Vs Unfractionated Heparin in Surgical Patients Receiving Deep Venous Thrombosis Prophylaxis

Author(s)
MONSIF IQBAL Mohi-ud-Din Islamic Medical College Mirpur Azad Kashmir,Pakistan
SHABAB HUSSAIN Khyber Medical University Institute of Medical Sciences DHQ Teaching Hospital KDA Kohat,Pakistan
ABDUL WAHID Frontier Medical and Dental College Abbotabad,Pakistan
KHAN KARIM DHQ Teaching Hospital KDA Kohat,Pakistan
VIQAR ASLAM MTI Lady Reading Hospital Peshawar,Pakistan
MUHAMMAD NASIR DHQ Teaching Hospital KDA Kohat,Pakistan
FAISAL KHAN Saidu Teaching Hospital Saidu Sharief Swat.Pakistan
INAM ULLAH Saidu Teaching Hospital Saidu Sharief Swat.Pakistan
Abstract
To evaluate low molecular weight heparin and unfractionated heparin in prophylaxis of venous thromboembolism in terms of post operative haemorrhage in surgical patients. Study design: Randomized control trail study Place and duration of duty: Surgical Department, POF Hospital Wah Cantt and DHQ Teaching Hospital KDA Kohat from 7th September 2018 to 7th March 2020. Methodology: Two hundred patients of moderate risk for venous thromboembolism were included in the study and divided into groups 1&2. Group 1 patients were receiving low molecular weight heparin and group 2 on unfractionated heparin. Patients in both groups were observed for post operative haemorrhage at 1st, 2ndand 3rd postoperative day. Results: Post operative haemorrhage from surgical wound was noticed in a single patient of group 1 and 11 pts of group 2. Conclusion: The chances of post operative haemorrhage are less in patient receiving Low molecular weight heparin in contrast to unfractionated heparin in prevention of venous thrombosis and embolism in surgical patients
Publication Details
Page(s) 151-152
Published Journal: Pakistan Journal of Medical and Health Sciences, Volume: 16, Issue: 05, Year: 2022

Request the full text from PASTIC

Keywords
Heparin, Venous thromboembolism, Post-operative haemorrhage
References
Zobeiri M .2011 .Prophylaxis for deep venous thrombosis: knowledge and practice of surgeons. Pak J Med Sci, 27 : 16-20.
Ahmed A .2005 .Prevention of deep vein thrombosis and pulmonary embolism in the perioperative period: A review. J Pak Med Assoc, 55(8) : 343-7.
Akhtar N,Deleu D,Kamran S. .2006 .Hematologic disorders and Cerebral venous thrombosis. J Pak Med Assoc, 56(11) : 498-500.
Barsam SJ,Patel R,Arya R .2013 .Anticoagulation for prevention and treatment of cancer-related venous thromboembolism. Br J Haematol, : .
Naz R,Naz S,Mehboob M,Khalid GH .2005 .Comparison of unfractionated heparin vs low molecular weight heparin in the treatment of acute deep vein thrombosis. J Coll Physicians Surg Pak Oct, 15(10) : 601-4.
Verso M,Agnelli G,Ageno W,Imberti D,Moia M,Palareti G .2012 .for the MASTER investigators. Long-term death and recurrence in patients with acute venous thromboembolism: The MASTER registry. Thromb Res, : .
.2004 .Serum lipids and lipoproteins in patients with documented Coronary Artery Disease. Pak J Pharm Sci Jul, 17(2) : 85-92.
Anderson FA,Spencer FA .2003 .107: I-9. Circulation, : .
Michota FA .2006 .Preventing venous thromboembolism in surgical patients. Cleve Clin J Med, 73(suppl 1) : 88s-94.
Attaya H,Wysokinski WE,Bower T,Litin S,Daniels PR,Slusser J,Heit JA,McBane RD .2013 .Three-month cumulative incidence of thromboembolism and bleeding after periprocedural anticoagulation management of arterial vascular bypass patients. J Thromb Thrombolysis, 35(1) : 100-6.
Zurawska U,Parasuraman S,Goldhaber SZ .2007 .Prevention of pulmonary embolism in general surgery patients. Circulation, 115 : 302-7.
.2013 .Prevalence of variants that confer risk for venous thromboembolism in an elderly population of North Eastern Brazil. Genet Mol Res, 12 : .
Harish J,Warkentin TE,Shaughnessy SG,Anand SS,Halperin JL,Raschke R .2001 .Heparin and low molecular weight heparin; mechanism of action, pharmacokinetics, dosing, monitoring, efficacy and safety. Chest, 119 : 64-94.
Eley KA,Parker RJ,Watt-Smith SR .2013 .Low molecular weight heparin in patients undergoing free tissue transfer following head and neck ablative surgery: review of efficacy and associated complications. Br J Oral Maxillofac Surg, : S0266-356.
Mirza W,Ashraf S,Fawad A .2005 .Physical versus combined physical and pharmacological prophylaxis against Deep Vein Thrombosis in patients undergoing major surgery. J Rawal Med Coll, 9(1) : 12-7.
Raskob G,Büller H,Prins M,Segers A,Shi M,Schwocho L .2013 .Edoxaban for the long-term treatment of venous thromboembolism: rationale and design of the Hokusai-VTE study. J Thromb Haemost, : 10.
JI Weitz .1997 .Low-molecular-weight heparins. N Engl J Med, 337 : 688-99.
.2001 .Prevention of venous thromboembolism. Chest, 119 : 132-75.
Praxis .2007 .. , 96(18) : 733-7.
.2011 .Bauer KA. Long-term management of venous thromboembolism: a 61-year-old woman with unprovoked venous thromboembolism. JAMA, 305(13) : 1336-45.
Prandoni P,Dalla Valle F,Piovella C,Tormene D,Pesavento R,Galanaud JP,Sevestre MA,Genty C .2014 .Incidence and predictors of venous thromboembolism recurrence after a first isolated distal deep vein thrombosis. J Thromb Haemost, 12(2) : 436-43.
.2012 .Comparison of bleeding complications and 3-year survival with low-molecularweight heparin versus unfractionated heparin for acute myocardial infarction: The FAST-MI registry. Arch Cardiovasc Dis, 105 : 347-54.
0

Citations

0

Downloads

151

Views